Content by this expert

Recently published by Alice

Article
Challenges of New Molecular Format Development
The storied rise of monoclonal antibodies (mAbs) in the pharmaceutical industry ― full of challenges...
Article
Accelerating timelines for development and manufacture of multi-specific antibodies
The critical need to rapidly develop new biological therapeutics was emphasized during the COVID-19...
eBook
Bispecific Antibody (BsAb) Development and Manufacture
In this e-book, Lonza experts review important aspects of developing and manufacturing bispecific...
Article
How to Accelerate Your Biotherapeutics’ Path to Clinic
Over the last few decades, many novel biotherapeutics have undergone clinical trial testing in the...
a scientist holds a small vial up to inspect it
Article
How to Accelerate Your Biotherapeutics' Path to Clinic
Over the last few decades, many novel biotherapeutics have undergone clinical trial testing in the...
Whitepaper/Executive Summary
Optimising bispecific antibody clonal cell selection with high-throughput analytics
It is possible to manufacture monoclonal antibodies using traditional methods, but the challenges...
Whitepaper/Executive Summary
De-risk Development and Manufacture of Bispecific Antibodies with Lonza
In this executive summary you'll discover why we are the CDMO to turn to when you want a faster path...
Article
Rapid Method Development to Overcome Challenges of Bi-specific Antibody Purification
The landscape of biopharmaceutical manufacturing is changing, with complex molecules such as...